Glyphosate: A Common Weedkiller May Induce Anxiety by Disrupting Gut Bacteria

Why It Matters

If glyphosate at levels deemed safe for humans can alter gut microbes and provoke anxiety‑related brain changes in animals, regulatory limits may need reassessment to protect mental health. This study highlights a potential environmental contributor to anxiety disorders, prompting further investigation in humans.

Key Takeaways

• Glyphosate at EPA limit triggers anxiety-like behavior in rats
• Overactivity observed in bed nucleus of stria terminalis
• Gut microbiome shows loss of Lactobacillus, reducing serotonin
• Behavioral changes appear after 10 weeks of exposure
• Study limited to male rats; sex differences remain unknown

Pulse Analysis

Glyphosate remains the world’s most widely applied herbicide, with annual applications exceeding 800 million kilograms and residues detected in food, water, and soil. S. Environmental Protection Agency has set the chronic reference dose at 2 mg per kilogram of body weight, a level considered non‑toxic to mammals because the compound targets a plant‑specific shikimate pathway absent in animal cells. However, recent epidemiological observations linking intensive glyphosate use to mood disturbances have spurred scientists to re‑examine this assumption.

The University of Puerto Rico study is the first to demonstrate that the EPA‑approved dose can provoke anxiety‑like behavior in a rodent model, challenging the long‑standing safety narrative. The experiment points to the gut‑brain axis as the conduit for glyphosate’s neurobehavioral effects. Sequencing of fecal samples revealed a sharp decline in Lactobacillus species, bacteria that convert dietary amino acids into precursors of serotonin, a neurotransmitter that dampens fear circuits. The loss of these microbes coincided with heightened activity in the bed nucleus of the stria terminalis, a deep‑brain structure that orchestrates sustained anxiety. By disrupting manganese availability, glyphosate may impair bacterial metabolism, indirectly lowering central serotonin levels and sensitizing threat‑processing pathways.

These findings carry weighty implications for public health policy. If chronic exposure at current regulatory limits can reshape the microbiome and trigger maladaptive anxiety responses in animals, the same mechanisms could operate in humans, especially given widespread dietary glyphosate residues. Policymakers may need to incorporate neurobehavioral endpoints and microbiome health into risk assessments, while researchers should prioritize longitudinal human studies that measure gut composition, serotonin biomarkers, and mental‑health outcomes. Ultimately, the study underscores the necessity of viewing chemical safety through a holistic, systems‑biology lens rather than isolated toxicological endpoints.